Artica Therapeutics
Biotech · Leiden, NL
Develops small-molecule covalent therapies (targeting GPCRs) for autoimmune and inflammatory disorders.
Funding history
| Date | Round | Amount |
|---|
| Nov 2023 | Seed Leiden-based Artica Therapeutics raised a EUR12M seed co-led by Thuja Capital and Seroba for its covalent small-molecule pipeline. | $12.9M |
Investors
BioGeneration VenturesInnovationQuarterSerobaThuja Capital
Similar companies in Biotech
Explore funding flow on EquityFlow →